What is the market doing?
What the tape says about LXRX
Lexicon Pharmaceuticals, Inc. is +107% over the past year while the S&P 500 is +23%: 85 points ahead of the market.
+107%
1-year return · S&P 500 +23%
- vs 200-day average
- +37%
vs 200-day average · a clear uptrend
- RSI (14)
- 48
RSI (14) · neutral
- Below its 52-week high
- −7.2%
Below its 52-week high
Details›
- Last close2026-08-26
- $2.32
- 1 monthS&P 500 +3.7%
- +0.43%
- 1 yearS&P 500 +23%
- +107%
- 5 yearsS&P 500 +87%
- −36%
- vs 50-day average$2.20
- +5.4%
- 52-week high
- $2.50
- 52-week low
- $1.04
- Annualised volatility
- 110%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
- $2.7M
| Year | Return |
|---|---|
| 2026 (year to date) | +102% |
| 2025 | +55% |
| 2024 | −52% |
| 2023 | −20% |
| 2022 | −52% |
| 2021 | +15% |
| 2020 | −18% |
| 2019 | −37% |
| 2018 | −33% |
| 2017 | −29% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 7 of 10 | +12% |
| Feb | 10 | 5 of 10 | +0.16% |
| Mar | 10 | 4 of 10 | −7.8% |
| Apr | 10 | 4 of 10 | +0.02% |
| May | 10 | 5 of 10 | +8.1% |
| Jun | 10 | 8 of 10 | +7.8% |
| Jul | 11 | 5 of 11 | −2.5% |
| Aug | 11 | 3 of 11 | −2.2% |
| Sep | 10 | 4 of 10 | +8.0% |
| Oct | 10 | 5 of 10 | −2.2% |
| Nov | 10 | 5 of 10 | −4.4% |
| Dec | 10 | 3 of 10 | +10% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Biotechnology
The closest names by size in the same industry